Long duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease

Annals of Neurology

Volumn 42, Issue 2, 1997, Pages 245-248

  Zappia, Mario ^a   Colao, Rosanna ^a   Montesanti, Rita ^a   Rizzo, Milena ^a   Aguglia, Umberto ^a   Gambardella, Antonio ^a   Oliveri, Rosario Luciano ^a   Quattrone, Aldo ^a,b,c  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b CNR   (Italy)

^c Facolta di Medicina   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE;

ADMINISTRATION, ORAL; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR ACTIVITY; MOVEMENT; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0030756241     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410420217     Document Type: Article

References (17)

1. Muenter MD, Tyce GM. L-Dopa therapy of Parkinson's disease: plasma L-Dopa concentration, therapeutic response, and side effects. Mayo Clin Proc 1971;46:231-239
2. Quattrone A, Zappia M, Aguglia U, et al. The subacute levodopa test for evaluating long-duration response in Parkinson's disease. Ann Neurol 1995;38:389-395
3. Nutt JG, Woodward WR, Carter JH, Gancher ST. Effect of long-term therapy on the pharmacodynamics of levodopa: relation to on-off phenomenon. Arch Neurol 1992;49:1123-1130
4. Nutt JG, Carter JH, Woodward WR. Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the anti-parkinsonian effects. Neurology 1994; 44:1617-1622
5. Nutt JG, Carter JH, Woodward WR. Long-duration response to levodopa. Neurology 1995;45:1613-1616
6. Quattrone A, Zappia M. Oral pulse levodopa therapy in mild Parkinson's disease. Neurology 1993;43:1161-1163
7. Zappia M, Montesanti R, Colao R, Quattrone A. Usefulness of movement time in the assessment of Parkinson's disease. J Neurol 1994;241:543-550
8. Fahn S, Elton RL, and the Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, eds. Recent developments in Parkinson's disease. London: Macmillan, 1987:153-163
9. Gancher ST, Nutt JG, Woodward WR. Peripheral pharmacokinetics of levodopa in untreated, stable and fluctuating parkinsonian patients. Neurology 1987;37:940-944
10. Kempster PA, Frankel JP, Bovindon M, et al. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:718-723
11. Contin M, Riva R, Martinelli P, et al. Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations. Clin Neuropharmacol 1990;13:19-28
12. Durso R, Isaac K, Perry L, et al. Age influences magnitude but not duration of response to levodopa. J Neurol Neurosurg Psychiatry 1993;56:65-68
13. Gancher ST, Nutt JG, Woodward WR. Response to brief levodopa infusions in parkinsonian patients with and without fluctuations. Neurology 1988;38:712-716
14. Mouradian MM, Juncos JL, Fabbrini G, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part II. Ann Neurol 1988;24:372-378
15. Fabbrini G, Mouradian MM, Juncos JL, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part I. Ann Neurol 1988;24:366-371
16. CAPIT Committee: Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantation (CAPIT). Mov Disord 1992;7:2-13
17. Turjanski N, Fernandez W, Lees AJ. The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:771-775